The effect of sphingomyelin hydrolysis on triacylglycerol-rich lipoprotein secretion was examined in the human intestinal cell line, CaCo-2. Addition of sphingomyelinase decreased sphingomyelin and phosphatidylethanolamine by 60 and 20%, respectively. Sphingomyelin hydrolysis decreased the basolateral secretion of triacylglycerol mass, newly synthesized triacylglycerol, and apo B mass. Pulse-chase experiments with 135S]methionine demonstrated a decrease in apo B synthesis and a marked decrease in apo B100 and apo B48 secretion without altering apo Al secretion. Sphingomyelin hydrolysis did not change apo B mRNA levels nor apo B turnover. Phosphatidylcholine-specific phospholipase C did not decrease apo B synthesis or its basolateral secretion. Membrane protein kinase C (PKC) activity was decreased twofold after sphingomyelin hydrolysis. The PKC inhibitor staurosporine decreased apo B mass and newly synthesized apo B secretion. Sphingomyelinase and staurosporine together caused an additional decrease in apo B secretion suggesting that sphingomyelin hydrolysis decreased apo B secretion independently of its effect on PKC activity. Moreover, conditions that increase PKC activity did not increase apo B secretion. Cell-permeable analogs of ceramide decreased immunoreactive apo B secretion. Sphingosine was without effect. The hydrolysis of membrane sphingomyelin by intestinal or pancreatic neutral sphingomyelinase may lead to the accumulation of cellular ceramide, which, in turn, could inhibit triacylglycerol-rich lipoprotein secretion. (J.
Introduction
There is a recognized relationship between the two lipids sphingomyelin and cholesterol. Both lipids occupy similar cellular compartments ( 1). Sphingomyelin and cholesterol increase concomitantly within cells during aging, neoplastic transformation, and in atherosclerosis (2) (3) (4) . The sphingomyelin content of a membrane influences the movement and distribution of cholesterol within and among membranes (5) . It has been suggested that sphingomyelin has a molecular attraction or affinity for cholesterol that traps or solubilizes the sterol within the membrane. The close relationship of both lipids also ex-tends to their metabolism. Slotte and Bierman (6) and Gupta and Rudney (7) found that after the hydrolysis of membrane sphingomyelin, cholesterol is released from the plasma membrane. The cholesterol then enters intracellular pools, leading to alterations in the rate of synthesis and esterification of the sterol. Moreover, in the genetically inherited syndrome of Niemann-Pick disease, the accumulation of sphingomyelin within cells results in the disruption of normal cholesterol trafficking and metabolism (8) (9) (10) .
Evidence has been accumulating that supports a role for sphingomyelin metabolism in the signal transduction pathway (for review see references 11, 12) . Both sphingosine and ceramide, products ofsphingomyelin hydrolysis, have been implicated as biological effectors of cell function ( 13, 14) . Sphingosine is a potent inhibitor ofprotein kinase C (PKC)' activity in vitro as well as in cell culture ( 13) . In GH3 cells, for example, membrane sphingomyelin hydrolysis leads to the suppression of PKC activity ( 15) . This suggests that sphingomyelin catabolism can alter cell function by the liberation of sphingosine or ceramide from the cell membrane. It is likely that membranebound neutral sphingomyelinase plays an important role in the hydrolysis of plasma membrane sphingomyelin and hence, in the initiation of the signal transduction pathway.
Our laboratory has recently demonstrated the existence of neutral sphingomyelinase activity in human pancreatic juice, human small intestine, and in CaCo-2 cells ( 16). Moreover, it was observed that after sphingomyelin hydrolysis of CaCo-2 cell membranes, less cholesterol mass was secreted basolaterally. Thus, in intestinal absorptive cells, changes in sphingomyelin metabolism, with its associated changes in cholesterol metabolism and release of biological effectors, could lead to alterations in the assembly and/or secretion of triacylglycerolrich lipoprotein particles. The present study was (Irvine, CA). Oleic acid, fatty acid poor bovine serum albumin, triglyceride analysis kit, salmon sperm, dextran sulfate, prestained gel electrophoresis standards (molecular mass range 25-180 kD), octadecylamine, sphingomyelin, sphingomyelinase, phosphatidylcholine-specific phospholipase C, staurosporine, monoolein, taurocholate, Histone Ills, 4#3-phorbol 12-myristate 13-acetate (PMA), and Triton X-100 were purchased from Sigma Chem. Co. (St. Louis, MO). N-Hexanoylsphingosine (C6-Cer) and N-acetylsphingosine (C2-Cer) were obtained from Matreya, Inc. (Chalfont, PA). Rabbit polyclonal antibody (IgG fraction) specific for apo B was purchased from Calbiochem (San Diego, CA). Protein A bound to sepharose was from Repligen Corp. (Cambridge, MA). Apo B, apo B monoclonal antibody (clone 1607) (IgG2b fraction purified by column chromatography), apo Al monoclonal antibody, and apo B sheep immunopurified polyclonal antibody conjugated to horseradish peroxidase were from BIODESIGN International (Kennebunkport, ME). Bovine phosphatidylserine was purchased from Avanti Polar Lipids (Pelham, AL ( 17, 18) .
Measurement oflipid synthesis. The rates of cholesteryl ester, triglyceride, and phospholipid synthesis within cells and that secreted into the basolateral medium were determined as previously described ( 17) .
Apo B and ceramide mass. Apo B mass within cells and that secreted into the basolateral medium were estimated by sandwich ELISA as described ( 18 ) . Ceramide was estimated using diacylglycerol kinase as described by Preiss et al. ( 19) . The ceramide phosphates were separated on silica gel G plates (Fisher Scientific, Pittsburgh, PA) using solvent system chloroform/acetone/methanol/acetic acid/water ( 10/ 4/2/2/ 1) (20). The 32P-radiolabeled bands were visualized by autoradiography and the band corresponding to ceramide was counted in Budget Solve (Research Products International Corp., Elk Grove Village, IL) by liquid scintillation spectroscopy. The 32P-labeled ceramide phosphates made from 0, 50, 100, 250, and 500 pmol of C6-Cer (Matreya, Inc.) were used as standards to quantitate the amount of ceramide present within cells.
Apo B and apo Al synthesis and degradation. CaCo-2 cells were cultured on 6.5 mm Transwell inserts (Costar Corp., Cambridge, MA). On day 14, the cells were washed with M 199 and incubated for 16 h in M 199 medium containing 1 mM oleic acid attached to 330 ,M albumin in the presence or absence of 100 mU/ml sphingomyelinase. The next morning the cells were washed and preincubated for 1 h with methionine-free M 199. The cells were then pulsed for 2 h with 100 gCi of [35S] methionine/ 100 ,l of methionine-free medium. At the end of the incubation, the medium was removed and the cells were solubilized in 100 Ml of ice-cold cell lysis buffer (10 mM Na phosphate, pH 7.5, containing 5 mM EDTA, 5 mM EGTA, 100 mM NaCl, 1% (vol/vol) Triton X-100, 0.1% SDS, 0.5% (wt/vol) Na deoxycholate, 1 mM PMSF, 20MM leupeptin, 1 mM DTT, 1 mM methionine, and 0.1 mM cysteine). The cell extract was transferred to a 1 .5-ml Eppendorf tube.
The filter was rinsed with 100 Al ofthe cell lysis buffer. The two extracts were combined and made to 1 ml with cell lysis buffer and sonicated for 10 s. The basal medium was diluted to 1 ml with cell lysis buffer and transferred to a 1 .5-ml Eppendorf tube. Samples of the cell extract and the medium were taken for estimation ofTCA-precipitable radioactivity incorporated into total proteins. A portion of the cell extract was also taken for protein determination.
To estimate apo AI and apo B degradation, cells were pulsed for 30 min with 200 MCi of [35S] methionine. The inserts were transferred to a new 24-well plate containing 0.6 ml of M 199, 1 mM methionine, and 0.1 mM cysteine. The cells were then incubated in M 199 containing 1 mM methionine and 0.1 mM cysteine with or without the treatment as described in the figure legends. At the indicated time, the cells were harvested in 0.2 ml of cell lysis buffer. The cell homogenate and basal medium were analyzed as described above for estimation of synthesis.
Immunoprecipitation ofapo B andAL. Aliquots from cell and basolateral medium containing similar amounts of TCA-precipitable counts ( -5 X 106) were precleared of nonspecific counts by incubation with 0.05 ml ofprotein A attached to Sepharose (binding capacity, 4 mg human IgG/ml) on a tube rocker for 1 h at 40C. This was followed by centrifugation for 10 min at 13,000 g in a refrigerated microfuge. To the supernatant was added rabbit immunopurified polyclonal antibody directed against human apo B or Al. The amount ofantibody used was in excess as estimated by repeating the immunoprecipitation on the supernatant from the first immunoprecipitation. The samples were incubated for 18 h at 4°C in a rocker. The antigen-antibody complexes were precipitated with 0.05 ml ofprotein A bound to Sepharose. The samples were rocked for 1 h and centrifuged for 30 s at 13,000 g. The pellet containing the antigen-antibody complex bound to protein A was washed six times with 1 ml ofcell lysis buffer and once with 1 ml of phosphate-buffered saline. The washed pellet was taken up in 0.04 ml of lx Laemmli sample buffer and the proteins were separated on 5% stacking and 8% separating porous gels as described by Doucet et al. (21 ) . After electrophoresis, the gels were treated with fixative solution (5% methanol, 7% acetic acid) for 30 min, washed three times with distilled water, and soaked for 30 min at room temperature in 1 M sodium salicylate. The gels were dried at 80°C for 2 h and the radioactive bands were detected by exposing the gels to Kodak X-Omat AR film for 48-72 h. The radioactivity from gel portions corresponding to apo B 100, apo B48, and apo AI bands was determined by liquid scintillation.
Apo B mRNA estimation. After incubating CaCo-2 cells for 16 h with 100 mU/ml of sphingomyelinase, RNA was extracted from the cells with acid guanidium isothiocyanate/phenol/chloroform mixture as described by Chomczynski and Sacchi (22). 1-8 Mg of total RNA was applied to nylon membrane filters (Nytran; Midwest Scientific, Valley Park, MO) via dot-blot apparatus. The filters were dried at 80°C in a vacuum oven. Prehybridization was performed at 42°C for 2 h in buffer containing 20 ml formamide, 2 ml of20% SDS, 0.4 ml ofsalmon sperm (10 mg/ml), and 7.4 ml of diethylpyrocarbonate water. After labeling the respective cDNA probes by random priming (23), duplicate filters were hybridized with either 32P-apo B cDNA or 32P-a-actin cDNA. The filters were washed twice for 15 min at room temperature in 6x SSPE and 0.1% SDS, once at 42°C for 30 min in lx SSPE and 0.1% SDS, and once at 65°C for 45 min in lx SSPE and 0.1% SDS. The filters were exposed to x-ray film with intensifying screens for 24-48 h. mRNA abundance for apo B and a-actin were quantitated by laser densitometry of the autoradiograms. The densities of apo B mRNA were normalized to the densities of a-actin mRNA.
PKC activity. After the incubation described in the figure legend, cells were washed three times with phosphate buffered saline and placed on ice. Cells from three to four wells were scraped into 500 ,ul of PKC homogenization buffer (20 mM Tris-HCl, 3 mM EGTA, 50 mM 2-mercaptoethanol, pH 7.5). Separation of cytosolic and particulate fractions and assay for PKC activity were performed as previously described with minor modifications (24) . All procedures were conducted at 4°C. Briefly, the homogenate was sonicated twice for 15 s (lowest output of a Branson sonicator; Branson Ultrasonics Corp., Danbury, CT) and then centrifuged at 500 g for 10 min. The supernatant was removed and centrifuged at 100,000 g for 30 min (L8-M ultracentrifuge in T-875 fixed angle rotor; Beckman Instruments, Inc., Fullerton, CA). The supernatant (cytosolic fraction) was aspirated and the pellet was extracted with 500 Ml of PKC homogenization buffer containing 0.2% Triton X-100 and centrifuged at l00,O00gfor 30 min. The supernatant (membrane fraction) was used without further purification to measure PKC activity. PKC activity in the cytosolic fraction was either measured directly or after further chromatography on DEAE Sephacel. For DEAE chromatography, the cytosolic fraction was applied to a 1-ml column ofDEAE Sephacel then washed with 4 ml ofhomogenization buffer followed by elution of PKC into 2 ml of homogenization buffer containing 0.1 M NaCl. (Whatman, Inc., Clifton, NJ) and the unreacted [,y-32P]ATP removed by washing four times for 10 min each in 400 ml of 75 mM phosphoric acid. The paper was rinsed in ethyl alcohol and then dried. The samples were cut out and quantitated by liquid scintillation counting. Background counts were less than 0.1% of total counts. PKC activity was determined as the difference between the kinase activity measured in the presence and absence of phosphatidylserine, PMA, and calcium. Cell viability. Viability of cells grown on semipermeable membranes was evaluated by trypan blue exclusion and by measuring the release of cellular lactate dehydrogenase (LDH) ( 18 ) . Sphingomyelinase had no effect on cell viability as determined by these parameters.
Chemical analysis. Protein was measured according to the method of Bradford (25) or Lowry et al. (26) . Triglyceride mass was measured as previously described (27) . Phospholipid mass was estimated by the method described by Chalvardjian and Rudnicki (28) .
Results
Phospholipid mass. Table I shows the phospholipid content remaining in CaCo-2 cells after a 16-h incubation with 100 mU/ml of sphingomyelinase. In control cells, sphingomyelin constituted 10% ofthe total phospholipids. After incubating with sphingomyelinase, 60% of the sphingomyelin was depleted. The amount of phosphatidylcholine remaining in cells after sphingomyelin hydrolysis was unchanged from controls. Similar results were obtained when labeled choline was used to estimate the amounts of phosphatidylcholine and sphingomyelin remaining in cells after treatment with this concentration of sphingomyelinase ( 16) . In cells incubated with sphingomyelinase, phosphatidylethanolamine mass was also decreased (P < 0.05). In another experiment, in which cells were first steady state labeled with [3H] ethanolamine before their incubation with sphingomyelinase, a 20% decrease in phosphatidylethanolamine after sphingomyelin hydrolysis was confirmed (data not shown).
Triacylglycerol transport. To address the effect of sphingomyelin hydrolysis on newly synthesized triacylglycerol transport, CaCo-2 cells were grown on semipermeable micropore filters separating an upper and lower chamber. After a 2-h preincubation with 100 mU/ml of exogenous sphingomyelinase added to the apical medium, the cells were incubated for 1, 2, and 4 h with 25 MM of labeled oleate solubilized in a micelle containing 1 mM taurocholate and 50 AM cholesterol. The rate of incorporation of labeled oleate into cellular lipids and lipids secreted into the basolateral medium was determined. The results are shown in Fig. 1 . The rates of synthesis of cellular triacylglycerol and phospholipid were not altered by sphingo- Fig. 3, A B 48 the effect of sphingomyelin hydrolysis (Fig. 3) , the hydrolysis of phosphatidylcholine resulted in a modest increase in the PKC activity. There is recent evidence suggesting that lipid products released by the hydrolysis of membrane sphingomyelin can alter cellular biological function through the regulation of PKC activity (for review see references 11, 12) . To determine if sphingomyelin hydrolysis of CaCo-2 cell membranes altered PKC activity, cells were incubated for 16 h with 100 mU/ml of sphingomyelinase and PKC activity was measured (Fig. 6) . Compared to the activity in control cells, membranebound PKC was inhibited twofold after sphingomyelin hydrolysis. PKC activity in cytosol was also decreased after sphingomyelin hydrolysis, but because of interexperimental variability, the effect was not significant.
To investigate if the inhibition of apo B secretion after sphingomyelin hydrolysis was related to the decrease observed in PKC activity, cells were incubated for 16 h with oleic acid attached to albumin and the phorbol ester, PMA (1 AM), or the PKC inhibitor, staurosporine (0.1 M). The activity of PKC was undetectable in membranes prepared from cells incubated with the phorbol ester, and in in vitro assays containing membranes prepared from CaCo-2 cells, 0.01 uM staurosporine caused complete inhibition of PKC activity (data not shown). The effect ofPMA and staurosporine on the incorporation of [35IS methionine into apo B and apo Al within cells and apoproteins secreted into the basolateral medium was determined (Fig. 7, A and B) . Staurosporine did not alter the incorporation of labeled methionine into cellular apo B 100, apo B48, or apo AI. In contrast, the phorbol ester caused a decrease in the incorporation of label into both apoproteins. Similar to what was observed with sphingomyelinase treatment, however, both agents caused a marked decrease in the basolateral secretion oflabeled apo B I00 and apo B48 without markedly affecting the secretion of labeled apo AI.
Since apo B secretion was decreased under conditions in which PKC activity was inhibited, a possible relationship between PKC activity and apo B secretion was investigated. To determine if the stimulation of PKC activity would cause an increase in apo B secretion, cells were incubated for short periods with PMA or for 16 h with 1,2-dioctanoylglycerol, a cell permeable analog of diacylglycerol known to stimulate PKC activity. The incorporation of labeled methionine into apo B within cells and that secreted into the basolateral medium was then estimated (Fig. 8, A and B) . Diacylglycerol, at concentrations of 400 and 800 ,g/ml, did not alter the synthesis or the secretion of newly synthesized apo B. Likewise, short-term incubation with the phorbol ester did not increase the secretion of labeled apo B. In fact, there was a modest decrease in the amount secreted compared to control. Thus, although apo B secretion was decreased when cells were incubated with agents that inhibit PKC activity, the reverse was not true. Apo B secretion was not increased under conditions in which PKC activity would be stimulated.
The results, however, still do not exclude the possibility that sphingomyelin hydrolysis decreased apo B secretion by inhibiting PKC activity. To address this, cells were incubated for 16 h with 100 mU/ml of sphingomyelinase in the presence or ab- sence of 0.1 uM staurosporine. After the incubation, the amount of apo B mass secreted into the basolateral medium and the synthesis and secretion of newly synthesized apo B were determined (Fig. 9, A and B CELLS sized apo B. Apo Al secretion was not significantly altered by sphingomyelinase or sphingomyelinase and staurosporine together. The additive effects of sphingomyelinase and staurosporine on apo B secretion suggest that sphingomyelinase is acting through a mechanism that differs from that of staurosporine. Thus, the results suggest that sphingomyelin hydrolysis decreases apo B secretion by a mechanism that is independent of its effect on PKC activity. Sphingosine and ceramide analogs. Since the above combined data made PKC an unlikely candidate to explain the mechanism for the effect ofsphingomyelin hydrolysis on apo B secretion, the possibility that sphingosine or ceramide could be playing a role in apo B secretion was explored next. Cells were incubated for 16 h with sphingosine at concentrations of 50, 100, and 200 ,M and the amount of apo B mass secreted into the basolateral medium was determined (Table II) . Compared with controls, sphingosine did not alter the amount of apo B mass secreted. This was true whether sphingosine was added in an albumin solution (shown here) or in ethanol alone without the oleic acid-albumin solution (data not shown).
In contrast, when the cell-permeable analogs of ceramide, C2-Cer and C6-Cer, were added to cells in increasing concentrations, the amount of apo B mass secreted into the basolateral medium was significantly decreased in a dose-dependent fashion (Fig. 10) . In other experiments in which the ceramide analogs were added in ethanol alone, the trend of decreased apo B secretion remained, but the data were more variable and less convincing. The presence of albumin might increase the delivery of the ceramide analogs to the cells or active lipoprotein production might be required to cause the observed decrease in apo B mass secretion by ceramide. After sphingomyelin hydrolysis, the amount of ceramide mass that accumulated within cells was approximately twice the amount found in control cells (3.4±0.3 vs 1.3±0.2 nmol/mg protein, respectively, n = 9).
Discussion
The results of this study clearly demonstrate that after the hydrolysis of membrane sphingomyelin, there is a significant decrease in the basolateral secretion of triacylglycerols and apo B by cultured human intestinal cells. Several possible mechanisms to explain this observation were explored. Since most sphingomyelin is localized to the plasma membrane of cells, it could be argued that the loss of this structural phospholipid from the membrane could have altered its physical properties to the extent that cellular secretion was disrupted. This is an unlikely explanation for the decrease observed in apo B secretion, however, as the basolateral secretion ofnewly synthesized TCA-precipitable proteins, apo Al, and phospholipids were not significantly altered after sphingomyelin hydrolysis. Although physical properties of the apical membrane are likely to be altered after sphingomyelin hydrolysis, other mechanisms appear to be involved to explain a decrease in the secretion ofapo B and triacylglycerol from the basolateral membrane. It has been demonstrated that cholesterol synthesis is decreased and esterification is increased within cells after sphingomyelin hydrolysis as cholesterol leaves the plasma membrane and enters intracellular pools (6, 7, 16) . It is possible that this influx ofcholesterol with its accompanying changes in cholesterol metabolism could lead to a decrease in apo B secretion. We and others, however, have found little evidence to suggest that a change in cholesterol flux regulates apo B secretion. Similar to what is observed after sphingomyelin hydrolysis, the addition of 25-hydroxycholesterol to cells leads to a decrease in cholesterol synthesis and an increase in cholesterol esterification (31, 32) . In Hep G2 cells, 25-hydroxycholesterol was found to either increase, or have no effect on, apo B secretion (33) . We have observed that neither native cholesterol nor 25-hydroxycholesterol alters the rate of synthesis or secretion of apo B in CaCo-2 cells (Field, F. J., E. Born, H. Chen, and S. N. Mathur. 1994. Regulation of apolipoprotein b secretion by biliary lipids in CaCo-2 cells. J. Lipid Res. In press.). Thus, the decrease observed in apo B secretion after sphingomyelin hydrolysis is likely unrelated to the influx of cholesterol or the subsequent changes in cholesterol metabolism.
In our previous study using labeled choline to estimate the amount ofcellular sphingomyelin and phosphatidylcholine remaining after sphingomyelin hydrolysis, 100 mU/ml ofsphin-gomyelinase (the highest concentration used in this study) did not alter the amount of cellular phosphatidylcholine ( 16) . The present data substantiated our previous results. The amount of phosphatidylcholine mass remaining in cells incubated with sphingomyelinase was not significantly different from controls. This was important to readdress as the significance ofphosphatidylcholine in the normal assembly and secretion oftriacylglycerol-rich lipoproteins has been demonstrated (34) . However, loss of cellular phosphatidylcholine cannot be implicated as a mechanism for the decrease in apo B secretion after sphingomyelin hydrolysis in the present study. Moreover, the lack of effect of phosphatidylcholine-specific phospholipase C on apo B secretion provides further support that neither the loss of phosphatidylcholine mass nor the action of a phospholipase C enzyme play a role in the regulation of apo B secretion after sphingomyelin hydrolysis.
The amount of phosphatidylethanolamine remaining in cells after sphingomyelin hydrolysis, however, was less than in control cells. In hepatocytes, the methylation of phosphatidylethanolamine can substitute for the synthesis of phosphatidylcholine when the CDP-choline pathway is blocked (35) . This could be important for triacylglycerol-rich lipoprotein synthesis in choline-deficient animals in which the amount of phosphatidylcholine is severely limiting. As stated above, however, phosphatidylcholine is not limiting in intestinal cells incubated with sphingomyelinase. Although it cannot be excluded with certainty that a 20% decrease in phosphatidylethanolamine could cause the inhibition of apo B secretion observed here, to our knowledge there is no evidence to support the notion that phosphatidylethanolamine is important for the secretion of triacylglycerol-rich lipoproteins.
Ceramide and diacylglycerol are products that are generated during the hydrolysis of sphingomyelin (36, 37) . Ceramide can be further metabolized to sphingosine by deacylation. All three ofthese products have been implicated as biological mediators of the signal transduction pathway ( 11, 12) . Sphingosine is a recognized inhibitor of PKC, leading to the suppression of several biological events mediated by this important kinase ( 13) . Previous studies have documented a decrease in PKC activity and the regulation of PKC-mediated cellular events after sphingomyelin hydrolysis ( 15) . Since PKC activity was decreased by 50% in membranes prepared from cells incubated with sphingomyelinase, the generation of sphingosine was considered as a potential mechanism to explain the decrease in PKC activity. Moreover, the possible involvement of PKC in the secretion ofapo B was postulated (38) .
The present results, however, did not confirm this relationship. The addition ofexogenous sphingosine, in concentrations that would be expected to inhibit PKC activity, did not alter apo B secretion. Although inhibiting PKC activity with staurosporine or depleting cells of PKC by long-term incubation with phorbol ester decreased apo B secretion as did sphingomyelin hydrolysis, it cannot be said with certainty that these two events are related. Like phorbol esters, staurosporine can have marked effects on cell growth and differentiation (39) . Because apo B secretion by cultured intestinal cells is highly dependent upon their differentiation and maturity, agents that can alter these processes will likely interfere with apo B secretion (40, 41 ). Moreover, agents that stimulate PKC activity, such as 1,2-dioctanoylglycerol and short-term incubation with PMA, did not alter apo B secretion. In addition, adding to cells phosphatidylcholine-specific phospholipase C, which would increase the endogenous levels of 1,2-diacylglycerol, did not significantly alter the secretion ofapo B compared to the secretion of apo Al. Lastly and perhaps most convincingly, the effect of sphingomyelinase and staurosponne together on the secretion of immunoreactive and newly synthesized apo B was additive, suggesting that sphingomyelinase was acting through a mechanism that differed from that of staurosporine. Although these results do not completely exclude the possibility that apo B secretion is decreased by the inhibition of PKC, the data favor the notion that sphingomyelin hydrolysis decreases apo B secretion independently of its effect on PKC activity.
Ceramide levels were elevated twofold in cells after sphingomyelin hydrolysis. This metabolite ofsphingomyelin catabolism has been postulated to play an important role in cellular proliferation and differentiation (20, 42, 43) . Using cell-permeable analogs of ceramide, a significant decrease in the secretion of immunoreactive apo B by cells incubated with C6-Cer or C2-Cer was observed. Why ceramide accumulation within the cell should decrease apo B secretion is unknown. Pagano et al. (44) have demonstrated that both exogenously added ceramide and ceramide that is generated intracellularly after sphingomyelin hydrolysis accumulate within the Golgi apparatus. Recent data from these investigators have shown that cell permeable analogs of ceramide disrupt the trafficking of secretory GPs in CHO cells (45) . Since our results suggest that the predominate effect of sphingomyelin hydrolysis is the disruption of apo B secretion, ceramide that accumulates within the Golgi apparatus could potentially interfere with apo B secretion. Studies are in progress to address this question.
